Medications ›zoledronic acid anhydrous

zoledronic acid anhydrous

RxCUI 1546014 precise ingredient

Contraindicated with · 6

Diagnoses3

Pregnancy Reproduction Drug Hypersensitivity

Condition families3

Reproductive Physiological Phenomena Drug-Related Side Effects and Adverse Reactions Chemically-Induced Disorders

Indicated for · 29

Diagnoses10

Paget Disease, Extramammary Neoplasms, Ductal, Lobular, and Medullary Multiple Myeloma Neoplasms, Plasma Cell Paraproteinemias Hypercalcemia Adenocarcinoma Carcinoma Neoplasms, Glandular and Epithelial Water-Electrolyte Imbalance

Condition families19

Bone Neoplasms Hemostatic Disorders Blood Protein Disorders Calcium Metabolism Disorders Immunoproliferative Disorders Lymphoproliferative Disorders Bone Diseases Hemorrhagic Disorders Musculoskeletal Diseases Neoplasms by Histologic Type Neoplasms by Site Hematologic Diseases Hemic and Lymphatic Diseases Metabolic Diseases Vascular Diseases Neoplasms Nutritional and Metabolic Diseases Cardiovascular Diseases Immune System Diseases

MED-RT, published by the VA through NLM. Relationships attach at the ingredient level, not to a specific product or dose.

RADV audits Coding jobs Chart counter Hours & decimal time About Contact Help Terms Privacy

Innova Coding Suite extension — both tools in your browser: Add to Chrome · Add to Edge

InnovaRx — Innova Health Strategies. ICD-10-CM and the CMS-HCC risk adjustment models are published by CMS and NCHS and are in the public domain. Effective date 2026-10-22 travels in the URL, so this link shows anyone exactly what you see.